Natco Pharma announced that Johnson & Johnsons and Momenta Pharmaceuticals has filed a lawsuit against NATCO and its marketing partner Mylan Pharmaceuticals Inc. (Mylan) & others alleging infringement of two old Patents associated with 20mg/ml and 40mg/ml Glatiramer Acetate Injection. This lawsuit has been filed in the Pennsylvania Federal Court. NATCO and its marketing partner, Mylan believe this is a meritless suit for a product […]
Business Wire India Green hydrogen is key to achieving a circular economy. Graforce has developed a plasma electrolysis technology that can produce hydrogen from residual materials – with significantly lower manufacturing costs and higher yields. Graforce will be demonstrating its marketable methane and wastewater electrolysis plants and refueling systems at IFAT, the world’s leading trade fair for water, sewage and waste management. They demonstrate the immense […]
The drug is approved by the U.S. Food and Drug Administration (USFDA).
PAT for the quarter under review logged growth of 48.8% QoQ at Rs19.80 crore.
Gland Pharma Ltd is quoting at Rs 2870, down 0.16% on the day as on 13:19 IST on the NSE. The stock in last one year as compared to a 4.93% in NIFTY and a 10.73% lost in the Nifty Pharma index.
Business Wire India FEELM, the flagship atomization tech brand belonging to SMOORE, today announced that it has been awarded Red Dot Awards for Product Design 2022 for 4 innovative atomization products, including the world’s thinnest ceramic coil vape pod solution FEELM Air, eco-friendly non-nicotine disposable e-cigarette, and anti-dust mouthpiece hygienic e-cigarette. By virtue of creative product ideas and avant-garde design, these award-winning atomization products showcase […]
Company's exports for FY22 were reported at Rs204.9 crore.
Sales rise 36.55% to Rs 544.61 crore

IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016, BSE Enlistment Number (RA): 5016
ARN NO : 47791 (AMFI Registered Mutual Fund & Specialized Investment Fund Distributor), PFRDA Reg. No. PoP 20092018

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.